Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.
about
Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized TrialsThe effects of terlipressin on regional hemodynamics and kidney function in experimental hyperdynamic sepsis.Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients.From macrohemodynamic to the microcirculation.Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock.Vasopressin improves systemic hemodynamics without compromising mesenteric perfusion in the resuscitation of asphyxiated newborn piglets: a dose–response study
P2860
Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.
@en
Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.
@nl
type
label
Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.
@en
Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.
@nl
prefLabel
Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.
@en
Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.
@nl
P2093
P2860
P1476
Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock
@en
P2093
Christian Ertmer
Martin Westphal
Paolo Pietropaoli
P2860
P304
P356
10.1517/14656560903257808
P407
P577
2009-10-01T00:00:00Z